Association of HTERT MNS16A Polymorphism with Clinical Outcomes of North Indian Lung Cancer Patients Undergoing Platinum-based Doublet Chemotherapy

Overview

Journal Clin Transl Oncol

Specialty Oncology

Date 2024 Nov 28

PMID 39607580

Authors

Ishmeet Kaur

Heena Kansal

Sidhartha Singh

Navneet Singh

Siddharth Sharma

Affiliations

Soon will be listed here.

Abstract

Background: Telomerase has been linked to aging and cancer. The MNS16A polymorphism in the hTERT gene plays a significant role in modulating telomerase activity and highlights the complexity of telomere-related genetics in cancer research.

Experimental Design: We genotyped 401 lung-cancer samples treated with platinum-based chemotherapy to identify the MNS16A polymorphism. We assessed overall survival using the Kaplan-Meier method and Cox regression analysis for adjusted hazard ratios. Stratified analyses evaluated risks for subgroups based on clinicopathologic parameters, outcomes, and toxicity calculated.

Results: Our findings show no significant link between MNS16A polymorphism and lung-cancer survival. However, in squamous cell carcinoma (SQCC) patients, the SS genotype was associated with poorer survival (p = 0.004). Patients with LS + SS genotypes responded better to gemcitabine in univariate (p = 0.003) and multivariate analyses (p = 0.014). The LS genotype was linked to a lower risk of progression to stage 4 (p = 0.011) and metastasis (p = 0.015) but an increased risk of T4 tumor size (p = 0.026). No significant correlations were found between MNS16A polymorphism and treatment-related toxicities.

Conclusion: The MNS16A polymorphism does not significantly impact overall lung-cancer survival but affects specific subgroups, influencing certain lung-cancer subtypes and treatment responses while having limited predictive value for overall outcomes or toxicity risks.

References

Collins L, Haines C, Perkel R, Enck R . Lung cancer: diagnosis and management. Am Fam Physician. 2007; 75(1):56-63. View

Nooreldeen R, Bach H . Current and Future Development in Lung Cancer Diagnosis. Int J Mol Sci. 2021; 22(16). PMC: 8395394. DOI: 10.3390/ijms22168661. View

Mohan A, Garg A, Gupta A, Sahu S, Choudhari C, Vashistha V . Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care center. Lung India. 2020; 37(3):190-197. PMC: 7353932. DOI: 10.4103/lungindia.lungindia_333_19. View

Islami F, Stoklosa M, Drope J, Jemal A . Global and Regional Patterns of Tobacco Smoking and Tobacco Control Policies. Eur Urol Focus. 2017; 1(1):3-16. DOI: 10.1016/j.euf.2014.10.001. View

Artandi S, DePinho R . Telomeres and telomerase in cancer. Carcinogenesis. 2009; 31(1):9-18. PMC: 3003493. DOI: 10.1093/carcin/bgp268. View

de Lange T . Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005; 19(18):2100-10. DOI: 10.1101/gad.1346005. View

Blasco M . Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet. 2005; 6(8):611-22. DOI: 10.1038/nrg1656. View

Greider C, Blackburn E . Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 1985; 43(2 Pt 1):405-13. DOI: 10.1016/0092-8674(85)90170-9. View

Shay J, Wright W . Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov. 2006; 5(7):577-84. DOI: 10.1038/nrd2081. View

10.

Baird D . Variation at the TERT locus and predisposition for cancer. Expert Rev Mol Med. 2010; 12:e16. DOI: 10.1017/S146239941000147X. View

11.

Kyo S, Inoue M . Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?. Oncogene. 2002; 21(4):688-97. DOI: 10.1038/sj.onc.1205163. View

12.

Newbold R . The significance of telomerase activation and cellular immortalization in human cancer. Mutagenesis. 2002; 17(6):539-50. DOI: 10.1093/mutage/17.6.539. View

13.

Marchese P, Mollica V, Tassinari E, de Biase D, Giunchi F, Marchetti A . Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers. Expert Rev Mol Diagn. 2022; 22(11):997-1008. DOI: 10.1080/14737159.2022.2154148. View

14.

Wang L, Soria J, Chang Y, Lee H, Wei Q, Mao L . Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer. Oncogene. 2003; 22(46):7123-9. DOI: 10.1038/sj.onc.1206852. View

16.

Hofer P, Baierl A, Feik E, Fuhrlinger G, Leeb G, Mach K . MNS16A tandem repeats minisatellite of human telomerase gene: a risk factor for colorectal cancer. Carcinogenesis. 2011; 32(6):866-71. PMC: 3314280. DOI: 10.1093/carcin/bgr053. View

17.

Diler S, Polat F, Bingol G . The MNS16A VNTR polymorphism of the TERT gene in bladder cancer. Turk J Urol. 2020; 46(1):44-49. PMC: 6944421. DOI: 10.5152/tud.2019.19005. View

18.

Concetti F, Lucarini N, Carpi F, Di Pietro F, Dato S, Capitani M . The functional VNTR MNS16A of the TERT gene is associated with human longevity in a population of Central Italy. Exp Gerontol. 2013; 48(6):587-92. DOI: 10.1016/j.exger.2013.03.009. View

19.

Singh P, Sailu S, Palchamy E, Coumar M, Baluchamy S . Identification of a novel leukemic-specific splice variant of DNMT3B and its stability. Med Oncol. 2017; 34(8):145. DOI: 10.1007/s12032-017-1008-0. View

20.

Hiyama E, Hiyama K . Telomere and telomerase in stem cells. Br J Cancer. 2007; 96(7):1020-4. PMC: 2360127. DOI: 10.1038/sj.bjc.6603671. View

21.

Hofer P, Zochmeister C, Behm C, Brezina S, Baierl A, Doriguzzi A . MNS16A tandem repeat minisatellite of human telomerase gene: functional studies in colorectal, lung and prostate cancer. Oncotarget. 2017; 8(17):28021-28027. PMC: 5438627. DOI: 10.18632/oncotarget.15884. View